Study of Genetic Factors in Pheochromocytomas, Paragangliomas, and Related Conditions to Improve Diagnosis and Care

What this Trial Is About

Researchers are studying pheochromocytomas and paragangliomas, which are tumors arising from nerve-related cells that often run in families and have varied genetic causes. The study aims to find new genes involved in these tumors and to understand how specific genetic changes relate to disease features, helping guide diagnosis and follow-up care for patients and their relatives. This research focuses on improving knowledge about inherited cancer syndromes linked to these tumors. Participants will provide germline andor tumor samples for genetic screening to detect mutations. The study will analyze these genetic samples to identify both inherited and tumor-specific mutations that may drive tumor development. This observational study does not involve treatments but collects data to map genetic variations and their clinical impacts. During the study, researchers will review genetic data and clinical features from participants and their families. Outcomes include identifying mutations and related genetic variants, as well as other clinical signs associated with these conditions. The study typically takes around six months to complete the genetic analyses and will help improve genetic screening and monitoring strategies for affected individuals and at-risk family members.

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions